Evaluating BI Opportunities in the Pharma Industry
Price:
$1 895.00
Full Title: Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)
Introduction
As market pressures demand increased innovation and shorter time-to-market product lifecycles, pharmaceutical companies are evaluating alternative business models, focusing on technologies such as business intelligence (BI) tools -for translational medicine.
Scope
Examines essential ingredients of sales strategies for BI vendors serving the pharmaceutical industry
Identifies strategies vendors should use to develop more effective relationships and drive solution sales
Offers profiles of leading vendors selling BI tools to the Big Pharma and Biotech market
Highlights
Market factors are driving adoption of translational research and specifically BI solutions
BI opportunities exist at several levels within the pharmaceutical market
BI vendors with high market readiness will realize the most success in the pharmaceutical industry
Reasons to Purchase
Understand how to evaluate market opportunities for BI solutions in the pharmaceutical market
Discover new ways to leverage relationships as a tool to drive market penetration
Gain insight into Datamonitor’s perspective on what makes a vendor successful
